Spanish Red Biotech Pipeline

MSD

MK-1308A/Lenvatinib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: MK-1308A (Coformulated MK-1308/MK-3475), plus Lenvatinib (E7080/MK-7902) in First-line Therapy of Advanced Hepatocellular Carcinoma
Phase: 2Phase II in Spain, 1Phase I